Filtration plasmapheresis in vivo.
A continuous-flow filtration plasmapheresis system has been developed as an alternative to conventional techniques for conducting plasmapheresis from blood donors. The system was tested in two stages, nonreinfusion and continuous reinfusion. Donor safety, separation efficiency, and plasma quality were examined. These studies indicate that membrane plasmapheresis is feasible, safe to the donor, and yields sufficient plasma for either therapeutic or component therapy use.
D000328:Adult; D001798:Blood Proteins / Q000502:physiology; D004905:Erythrocyte Aging; D004906:Erythrocyte Count; D005260:Female; D005374:Filtration; D006454:Hemoglobins / Q000502:physiology; D006801:Humans; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D009504:Neutrophils; D010956:Plasmapheresis; D013997:Time Factors
D001798:Blood Proteins; D006454:Hemoglobins